Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome.
- 1 September 1990
- journal article
- case report
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 49 (9) , 725-727
- https://doi.org/10.1136/ard.49.9.725
Abstract
A 22 year old woman presented with lupus nephritis, hypertension, and intractable nephrotic syndrome. Albumin and furosemide given intravenously was ineffective. Captopril administered in a daily dose of 62.5 mg was associated with a reduction in proteinuria from 28 g/24 hours to 11.5 g/24 hours over 10 weeks, resulting in a weight reduction of 16 kg. This was achieved with relative preservation of renal function. Captopril should be considered in the treatment of intractable proteinuria in patients with lupus nephritis, or when cytotoxic drugs are refused, because of its efficacy and relative safety. Captopril should, however, be used as an adjunct and not as a substitute for standard treatment.Keywords
This publication has 9 references indexed in Scilit:
- Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal diseaseThe Journal of Pediatrics, 1988
- Beneficial Effect of Captopril on Systemic Lupus erythematosus-Like Disease in MRL 1pr/1pr MiceInternational Archives of Allergy and Immunology, 1988
- Angiotensin-converting enzyme inhibitors: considerations regarding proteinuria.1987
- Reduction of proteinuria by angiotensin converting enzyme inhibitionKidney International, 1987
- Antiproteinuric Effect of Captopril in Primary Glomerular DiseaseNephron, 1987
- Effect of Captopril on Heavy Proteinuria in Azotemic DiabeticsNew England Journal of Medicine, 1985
- Captopril and immune regulationKidney International, 1984
- Captopril Treatment of Hypertension and Renal Failure in Systemic Lupus erythematosusNephron, 1984